nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—HTR2C—type 2 diabetes mellitus	0.369	1	CbGaD
Mesoridazine—HTR6—Bromocriptine—type 2 diabetes mellitus	0.105	0.207	CbGbCtD
Mesoridazine—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0868	0.171	CbGbCtD
Mesoridazine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0612	0.12	CbGbCtD
Mesoridazine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0577	0.114	CbGbCtD
Mesoridazine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0552	0.109	CbGbCtD
Mesoridazine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0508	0.1	CbGbCtD
Mesoridazine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0267	0.0526	CbGbCtD
Mesoridazine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0247	0.0485	CbGbCtD
Mesoridazine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0202	0.0398	CbGbCtD
Mesoridazine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0194	0.0382	CbGbCtD
Mesoridazine—HTR2A—arteriole—type 2 diabetes mellitus	0.00295	0.195	CbGeAlD
Mesoridazine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00188	0.124	CbGeAlD
Mesoridazine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00126	0.0836	CbGeAlD
Mesoridazine—HTR2A—hindlimb—type 2 diabetes mellitus	0.00117	0.0773	CbGeAlD
Mesoridazine—DRD2—nerve—type 2 diabetes mellitus	0.00108	0.0713	CbGeAlD
Mesoridazine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000913	0.0603	CbGeAlD
Mesoridazine—HTR2A—artery—type 2 diabetes mellitus	0.000717	0.0474	CbGeAlD
Mesoridazine—HTR2A—nerve—type 2 diabetes mellitus	0.000711	0.047	CbGeAlD
Mesoridazine—HTR2A—endothelium—type 2 diabetes mellitus	0.000606	0.04	CbGeAlD
Mesoridazine—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000515	0.0341	CbGeAlD
Mesoridazine—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000515	0.034	CbGeAlD
Mesoridazine—DRD2—retina—type 2 diabetes mellitus	0.000447	0.0295	CbGeAlD
Mesoridazine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000418	0.0276	CbGeAlD
Mesoridazine—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000372	0.0246	CbGeAlD
Mesoridazine—HTR2A—retina—type 2 diabetes mellitus	0.000295	0.0195	CbGeAlD
Mesoridazine—Fluphenazine—CALM1—type 2 diabetes mellitus	0.000285	0.0504	CrCbGaD
Mesoridazine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000263	0.0174	CbGeAlD
Mesoridazine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000249	0.0165	CbGeAlD
Mesoridazine—HTR2A—kidney—type 2 diabetes mellitus	0.000244	0.0161	CbGeAlD
Mesoridazine—Propericiazine—ADRA2A—type 2 diabetes mellitus	0.000241	0.0427	CrCbGaD
Mesoridazine—Promethazine—CALM1—type 2 diabetes mellitus	0.000231	0.0408	CrCbGaD
Mesoridazine—Trifluoperazine—CALM1—type 2 diabetes mellitus	0.000228	0.0403	CrCbGaD
Mesoridazine—Perphenazine—CALM1—type 2 diabetes mellitus	0.000225	0.0398	CrCbGaD
Mesoridazine—Cyamemazine—HTR2C—type 2 diabetes mellitus	0.000222	0.0393	CrCbGaD
Mesoridazine—CYP2D6—kidney—type 2 diabetes mellitus	0.000222	0.0147	CbGeAlD
Mesoridazine—Metixene—HTR2C—type 2 diabetes mellitus	0.000207	0.0365	CrCbGaD
Mesoridazine—Chlorpromazine—CALM1—type 2 diabetes mellitus	0.000179	0.0316	CrCbGaD
Mesoridazine—HTR2A—liver—type 2 diabetes mellitus	0.000154	0.0102	CbGeAlD
Mesoridazine—Clemastine—CYP3A4—type 2 diabetes mellitus	0.000151	0.0266	CrCbGaD
Mesoridazine—Thiothixene—ADRA2A—type 2 diabetes mellitus	0.000149	0.0264	CrCbGaD
Mesoridazine—CYP2D6—liver—type 2 diabetes mellitus	0.00014	0.00928	CbGeAlD
Mesoridazine—Thiothixene—HTR2C—type 2 diabetes mellitus	0.000137	0.0243	CrCbGaD
Mesoridazine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	0.000131	0.0232	CrCbGaD
Mesoridazine—Fluphenazine—ADRA2A—type 2 diabetes mellitus	0.000129	0.0228	CrCbGaD
Mesoridazine—Fluphenazine—HTR2C—type 2 diabetes mellitus	0.000119	0.021	CrCbGaD
Mesoridazine—Propiomazine—HTR2C—type 2 diabetes mellitus	0.000114	0.0202	CrCbGaD
Mesoridazine—Alimemazine—CYP3A4—type 2 diabetes mellitus	0.000112	0.0198	CrCbGaD
Mesoridazine—Thioridazine—ADRA2A—type 2 diabetes mellitus	0.000111	0.0196	CrCbGaD
Mesoridazine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	0.000106	0.0188	CrCbGaD
Mesoridazine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	0.000104	0.0183	CrCbGaD
Mesoridazine—Thiothixene—CYP1A2—type 2 diabetes mellitus	0.000104	0.0183	CrCbGaD
Mesoridazine—Thioridazine—HTR2C—type 2 diabetes mellitus	0.000102	0.0181	CrCbGaD
Mesoridazine—Perphenazine—ADRA2A—type 2 diabetes mellitus	0.000102	0.018	CrCbGaD
Mesoridazine—Eletriptan—CYP3A4—type 2 diabetes mellitus	0.000102	0.018	CrCbGaD
Mesoridazine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	9.76e-05	0.0173	CrCbGaD
Mesoridazine—Mequitazine—CYP3A4—type 2 diabetes mellitus	9.64e-05	0.0171	CrCbGaD
Mesoridazine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	9.49e-05	0.0168	CrCbGaD
Mesoridazine—Fluphenazine—CYP2E1—type 2 diabetes mellitus	9.41e-05	0.0166	CrCbGaD
Mesoridazine—Perphenazine—HTR2C—type 2 diabetes mellitus	9.38e-05	0.0166	CrCbGaD
Mesoridazine—Promazine—ADRA2A—type 2 diabetes mellitus	9.19e-05	0.0163	CrCbGaD
Mesoridazine—Fluphenazine—CYP1A2—type 2 diabetes mellitus	8.95e-05	0.0158	CrCbGaD
Mesoridazine—Promazine—HTR2C—type 2 diabetes mellitus	8.46e-05	0.015	CrCbGaD
Mesoridazine—Thioridazine—CYP2E1—type 2 diabetes mellitus	8.11e-05	0.0143	CrCbGaD
Mesoridazine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	8.09e-05	0.0143	CrCbGaD
Mesoridazine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	7.74e-05	0.0137	CrCbGaD
Mesoridazine—Thioridazine—CYP1A2—type 2 diabetes mellitus	7.71e-05	0.0136	CrCbGaD
Mesoridazine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	7.44e-05	0.0132	CrCbGaD
Mesoridazine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	7.36e-05	0.013	CrCbGaD
Mesoridazine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	7.16e-05	0.0127	CrCbGaD
Mesoridazine—Perphenazine—CYP1A2—type 2 diabetes mellitus	7.08e-05	0.0125	CrCbGaD
Mesoridazine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	6.86e-05	0.0121	CrCbGaD
Mesoridazine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	6.55e-05	0.0116	CrCbGaD
Mesoridazine—Promazine—CYP1A2—type 2 diabetes mellitus	6.38e-05	0.0113	CrCbGaD
Mesoridazine—Acepromazine—ALB—type 2 diabetes mellitus	6.22e-05	0.011	CrCbGaD
Mesoridazine—Thioproperazine—ALB—type 2 diabetes mellitus	6.08e-05	0.0108	CrCbGaD
Mesoridazine—Pipotiazine—ALB—type 2 diabetes mellitus	5.98e-05	0.0106	CrCbGaD
Mesoridazine—Thiothixene—ALB—type 2 diabetes mellitus	5.98e-05	0.0106	CrCbGaD
Mesoridazine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	5.9e-05	0.0104	CrCbGaD
Mesoridazine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	5.62e-05	0.00993	CrCbGaD
Mesoridazine—Perphenazine—CYP3A4—type 2 diabetes mellitus	4.69e-05	0.00829	CrCbGaD
Mesoridazine—Promazine—CYP3A4—type 2 diabetes mellitus	4.23e-05	0.00747	CrCbGaD
Mesoridazine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	3.72e-05	0.00658	CrCbGaD
Mesoridazine—Chlorpromazine—ALB—type 2 diabetes mellitus	3.24e-05	0.00574	CrCbGaD
Mesoridazine—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	6.92e-06	6.74e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	6.92e-06	6.74e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.91e-06	6.73e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—LEP—type 2 diabetes mellitus	6.88e-06	6.71e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—APOE—type 2 diabetes mellitus	6.88e-06	6.71e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.85e-06	6.68e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.84e-06	6.67e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.8e-06	6.63e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.8e-06	6.63e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	6.79e-06	6.62e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—INS—type 2 diabetes mellitus	6.78e-06	6.61e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	6.72e-06	6.55e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	6.72e-06	6.55e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.69e-06	6.52e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.68e-06	6.51e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.67e-06	6.51e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.67e-06	6.5e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—RELA—type 2 diabetes mellitus	6.59e-06	6.42e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.57e-06	6.4e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.57e-06	6.4e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.56e-06	6.39e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.55e-06	6.39e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.55e-06	6.39e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	6.55e-06	6.39e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.53e-06	6.36e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	6.52e-06	6.36e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.52e-06	6.36e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.49e-06	6.33e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.45e-06	6.29e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	6.44e-06	6.28e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	6.44e-06	6.28e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—C3—type 2 diabetes mellitus	6.42e-06	6.26e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	6.4e-06	6.24e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	6.3e-06	6.14e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.23e-06	6.07e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.22e-06	6.07e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.21e-06	6.05e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	6.2e-06	6.04e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.17e-06	6.02e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.14e-06	5.99e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.12e-06	5.97e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.11e-06	5.96e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.11e-06	5.95e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AGT—type 2 diabetes mellitus	6.1e-06	5.95e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.09e-06	5.94e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.09e-06	5.94e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.09e-06	5.93e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	6.07e-06	5.92e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	6.07e-06	5.92e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.01e-06	5.86e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	6e-06	5.85e-05	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6e-06	5.85e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	6e-06	5.85e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	6e-06	5.85e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	5.99e-06	5.84e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.98e-06	5.83e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	5.98e-06	5.83e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	5.98e-06	5.83e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.96e-06	5.81e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.96e-06	5.81e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.95e-06	5.8e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.95e-06	5.8e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.94e-06	5.79e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	5.91e-06	5.76e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.91e-06	5.76e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.9e-06	5.76e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.89e-06	5.75e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.89e-06	5.74e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—INS—type 2 diabetes mellitus	5.88e-06	5.73e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	5.87e-06	5.72e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	5.87e-06	5.72e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.81e-06	5.67e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.8e-06	5.65e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.78e-06	5.64e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.73e-06	5.58e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.72e-06	5.57e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.71e-06	5.57e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.69e-06	5.55e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.69e-06	5.54e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.68e-06	5.54e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.66e-06	5.52e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.64e-06	5.49e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.62e-06	5.48e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.62e-06	5.48e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—RELA—type 2 diabetes mellitus	5.6e-06	5.46e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.56e-06	5.42e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	5.55e-06	5.41e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.55e-06	5.41e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.53e-06	5.39e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	5.53e-06	5.39e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	5.45e-06	5.32e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.45e-06	5.31e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.43e-06	5.29e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.42e-06	5.28e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.4e-06	5.26e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.33e-06	5.2e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.32e-06	5.19e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	5.29e-06	5.16e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.23e-06	5.1e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	5.19e-06	5.06e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.18e-06	5.05e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.18e-06	5.05e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—SRC—type 2 diabetes mellitus	5.18e-06	5.05e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.16e-06	5.03e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.16e-06	5.03e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	5.15e-06	5.02e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	5.1e-06	4.98e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.1e-06	4.98e-05	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.1e-06	4.97e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	5.09e-06	4.97e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	5.05e-06	4.93e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.05e-06	4.92e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.04e-06	4.92e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.02e-06	4.9e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.02e-06	4.89e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.02e-06	4.89e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.01e-06	4.89e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	5.01e-06	4.89e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.01e-06	4.89e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.99e-06	4.87e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.95e-06	4.82e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.94e-06	4.81e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.93e-06	4.81e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.93e-06	4.81e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.93e-06	4.81e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.93e-06	4.8e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.92e-06	4.8e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.91e-06	4.79e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.9e-06	4.78e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	4.88e-06	4.76e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	4.85e-06	4.73e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.85e-06	4.73e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.84e-06	4.72e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.82e-06	4.7e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	4.8e-06	4.68e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.77e-06	4.65e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.77e-06	4.65e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.74e-06	4.62e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.72e-06	4.6e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.69e-06	4.57e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.68e-06	4.56e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.63e-06	4.51e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.63e-06	4.51e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.6e-06	4.49e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	4.55e-06	4.44e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.55e-06	4.44e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.55e-06	4.44e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.54e-06	4.43e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.48e-06	4.36e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.48e-06	4.36e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.47e-06	4.36e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.47e-06	4.36e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	4.46e-06	4.35e-05	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.44e-06	4.33e-05	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.42e-06	4.31e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.4e-06	4.29e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	4.4e-06	4.29e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.4e-06	4.29e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.4e-06	4.29e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.38e-06	4.27e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.37e-06	4.26e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.35e-06	4.24e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	4.32e-06	4.22e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.28e-06	4.18e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	4.28e-06	4.18e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	4.25e-06	4.15e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	4.24e-06	4.13e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	4.21e-06	4.11e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.2e-06	4.1e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	4.19e-06	4.08e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.16e-06	4.05e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	4.14e-06	4.03e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.14e-06	4.03e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.11e-06	4.01e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.09e-06	3.99e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.03e-06	3.93e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.01e-06	3.91e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.93e-06	3.83e-05	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.9e-06	3.8e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.86e-06	3.77e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.85e-06	3.76e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.84e-06	3.74e-05	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.84e-06	3.74e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	3.83e-06	3.74e-05	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.83e-06	3.73e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	3.81e-06	3.72e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.8e-06	3.71e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.79e-06	3.7e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.78e-06	3.68e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.77e-06	3.67e-05	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.77e-06	3.67e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.73e-06	3.64e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.73e-06	3.64e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.71e-06	3.62e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.71e-06	3.61e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.69e-06	3.6e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.65e-06	3.56e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.62e-06	3.53e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.61e-06	3.52e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.59e-06	3.5e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.58e-06	3.49e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.55e-06	3.46e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.55e-06	3.46e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.54e-06	3.45e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.53e-06	3.44e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.49e-06	3.4e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	3.49e-06	3.4e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.48e-06	3.4e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.48e-06	3.39e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.43e-06	3.34e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.42e-06	3.33e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.41e-06	3.32e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.37e-06	3.28e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.36e-06	3.28e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.34e-06	3.26e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	3.32e-06	3.24e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	3.31e-06	3.23e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.3e-06	3.22e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.28e-06	3.2e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.25e-06	3.17e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.23e-06	3.14e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.22e-06	3.14e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.22e-06	3.14e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.17e-06	3.09e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.17e-06	3.09e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.17e-06	3.09e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.01e-06	2.93e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.96e-06	2.89e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.96e-06	2.89e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.95e-06	2.88e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.95e-06	2.88e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.91e-06	2.83e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.9e-06	2.83e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.9e-06	2.83e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.9e-06	2.82e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.85e-06	2.78e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.73e-06	2.66e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.58e-06	2.52e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	2.57e-06	2.5e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.38e-06	2.32e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.37e-06	2.31e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.27e-06	2.21e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.23e-06	2.17e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.23e-06	2.17e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.19e-06	2.14e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.09e-06	2.04e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.06e-06	2.01e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.05e-06	2e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.02e-06	1.97e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.46e-06	1.42e-05	CbGpPWpGaD
